Загрузка...
Characterization of Inhibitory Anti-insulin-like Growth Factor Receptor Antibodies with Different Epitope Specificity and Ligand-blocking Properties: IMPLICATIONS FOR MECHANISM OF ACTION IN VIVO
Therapeutic antibodies directed against the type 1 insulin-like growth factor receptor (IGF-1R) have recently gained significant momentum in the clinic because of preliminary data generated in human patients with cancer. These antibodies inhibit ligand-mediated activation of IGF-1R and the resulting...
Сохранить в:
Главные авторы: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
American Society for Biochemistry and Molecular Biology
2009
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2665079/ https://ncbi.nlm.nih.gov/pubmed/19211557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M809709200 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|